The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

An endogenous selective estrogen receptor modulator, 27-hydroxycholesterol, has a negative influence on bone homeostasis, according to a research team from the USA. “Osteoporosis is an important ...

(Bloomberg) --Trading of futures and options on the Chicago Mercantile Exchange was halted by a data-center fault, causing hours of disruption to markets across equities, foreign exchange, bonds and ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

U.S. Army Space and Missile Defense Command is preparing to open the aperture of its role in defense of the homeland as threats evolve and grow. A piece of the $175 billion Golden Dome pie could give ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and currently holds a Life, ...